CORPORATE INFO
FOR INVESTORS
OUR PRODUCTS
BUSINESS DEVELOPMENT
CONTACT US
HOME
Menu
Overview
Mission Statement
Strategy
History
Management Team
Board of Directors
News
Press Releases
Corporate News
Awards
PRESS RELEASES
COMMUNIQUÉS DE PRESSE (Français)
2009
|
2008
|
2007
|
2006
|
2005
|
2004
|
2003
|
2002
|
2001
|
2000
|
1999
|
1998
|
1997
|
July 29, 2010
NOTICE OF PALADIN LABS' 2010 SECOND QUARTER RESULTS CONFERENCE CALL
(Also in
PDF
format)
June 8, 2010
PALADIN TO PRESENT AT THE NEEDHAM AND JEFFERIES CONFERENCES IN NEW YORK CITY
(Also in
PDF
format)
May 6, 2010
PALADIN REPORTS 2010 RECORD FIRST QUARTER FINANCIAL RESULTS
(Also in
PDF
format)
April 29, 2010
NOTICE OF PALADIN LABS' 2010 FIRST QUARTER RESULTS CONFERENCE CALL
(Also in
PDF
format)
April 6, 2010
PALADIN LABS OBTAINS CANADIAN APPROVAL FOR SEASONIQUE(R)
(Also in
PDF
format)
March 16, 2010
PALADIN MAKES FIRST STEP INTO EMERGING MARKETS THROUGH STRATEGIC INVESTMENT IN PHARMAPLAN
(Also in
PDF
format)
March 3, 2010
PALADIN AND SPEPHARM ANNOUNCE NEW STRATEGIC RELATIONSHIP AND FINANCING
(Also in
PDF
format)
March 1, 2010
PALADIN ANNOUNCES NORMAL COURSE ISSUER BID AND AUTOMATIC SHARE PURCHASE PLAN
(Also in
PDF
format)
February 25, 2010
BTG AND PALADIN COMPLETE AGREEMENT FOR DIGIFAB FOR THE TREATMENT OF DIGOXIN TOXICITY
(Also in
PDF
format)
February 25, 2010
PALADIN REPORTS FOURTEENTH CONSECUTIVE YEAR OF RECORD REVENUES
(Also in
PDF
format)
February 23, 2010
PALADIN TO PRESENT AT THE RBC CAPITAL MARKETS HEALTHCARE CONFERENCE IN NEW YORK CITY
(Also in
PDF
format)
February 18, 2010
NOTICE OF PALADIN LABS' 2009 FOURTH QUARTER RESULTS CONFERENCE CALL
(Also in
PDF
format)
February 18, 2010
PALADIN LABS ANNOUNCES AMENDMENT TO R&D AGREEMENT WITH ISOTECHNIKA PHARMA INC.
(Also in
PDF
format)
February 4, 2010
PALADIN GRANTED PRIORITY REVIEW STATUS FOR ABSTRAL(R) BY HEALTH CANADA
(Also in
PDF
format)
HOME
|
SITE MAP
|
LEGAL DISCLAIMER
